The Clinical Trade-off between Rapid Hemodynamic Stabilization and Respiratory Morbidity in Pediatric Dengue Shock Syndrome: A Meta-Analysis of Colloid versus Crystalloid Resuscitation
DOI:
https://doi.org/10.37275/bsm.v10i6.1601Keywords:
Colloids, Crystalloids, Dengue shock syndrome, Fluid resuscitation, PediatricAbstract
Background: Fluid resuscitation is the cornerstone therapy for pediatric Dengue Shock Syndrome (DSS), a condition defined by profound endothelial hyperpermeability. The choice between crystalloids and colloids presents a clinical paradox. Crystalloids are standard first-line therapies, whereas colloids offer rapid intravascular expansion for refractory shock. This study quantifies the trade-off between the rapid hemodynamic stabilization provided by colloids and the subsequent iatrogenic risk of respiratory morbidity in pediatric DSS.
Methods: Following PRISMA guidelines, a systematic review and meta-analysis were conducted. We searched MEDLINE, Scopus, and Cochrane databases for original randomized controlled trials (RCTs) and cohort studies comparing crystalloid and colloid regimens in pediatric DSS. To address methodological heterogeneity, efficacy outcomes (time to hemodynamic stabilization) from RCTs and safety outcomes (respiratory morbidity) from observational cohorts were analyzed separately. Standardized mean differences (SMD) and odds ratios (OR) with 95% confidence intervals (CI) were calculated using random-effects models.
Results: Seven studies encompassing 2,477 pediatric patients were included. Meta-analysis of RCTs demonstrated that colloid-containing regimens achieved significantly faster initial hemodynamic stabilization compared to crystalloid-only regimens (SMD -0.62, 95% CI -0.85 to -0.39). Conversely, meta-analysis of cohort data revealed that mixed or colloid-heavy regimens were associated with a markedly increased risk of respiratory morbidity and mechanical ventilation requirements (OR 2.45, 95% CI 1.68 to 3.57). Overall shock recovery was prolonged in mixed-fluid groups.
Conclusion: A definitive clinical trade-off exists in pediatric DSS management. Colloids rapidly restore early hemodynamics but significantly increase late-stage respiratory morbidity and ventilation requirements. This supports a restrictive, crystalloid-first resuscitation strategy. Future randomized trials are urgently needed to specifically evaluate the safety of natural colloids, such as 5% albumin, versus synthetic starches and gelatins.
Authors
- Ni Nyoman Putri Widyastiti1*
- I Nyoman Putra Arcana2
- 1General Practitioner, Windu Husada Hospital, Badung, Indonesia
- 2Department of Pediatrics, Windu Husada Hospital, Badung, Indonesia
Corresponding author Ni Nyoman Putri Widyastiti — widyastitiputri@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
